S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

Seattle Genetics News Headlines (NASDAQ:SGEN)

$118.07
-0.15 (-0.13 %)
(As of 02/17/2020 11:21 AM ET)
Today's Range
$116.28
Now: $118.07
$118.60
50-Day Range
$105.47
MA: $112.49
$118.64
52-Week Range
$62.90
Now: $118.07
$124.32
Volume630,187 shs
Average Volume951,058 shs
Market Capitalization$20.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta2

Headlines

Seattle Genetics (NASDAQ SGEN) News Headlines

Source:
DateHeadline
Zacks: Brokerages Anticipate Seattle Genetics, Inc. (NASDAQ:SGEN) Will Announce Quarterly Sales of $210.35 MillionZacks: Brokerages Anticipate Seattle Genetics, Inc. (NASDAQ:SGEN) Will Announce Quarterly Sales of $210.35 Million
www.americanbankingnews.com - February 15 at 3:46 AM
Analysts Offer Predictions for Seattle Genetics, Inc.s FY2021 Earnings (NASDAQ:SGEN)Analysts Offer Predictions for Seattle Genetics, Inc.'s FY2021 Earnings (NASDAQ:SGEN)
www.americanbankingnews.com - February 14 at 12:11 PM
Seattle Genetics Experimental Breast Cancer Drug Receives Priority Review From the FDASeattle Genetics' Experimental Breast Cancer Drug Receives Priority Review From the FDA
www.fool.com - February 13 at 2:35 PM
Zacks: Brokerages Anticipate Seattle Genetics, Inc. (NASDAQ:SGEN) to Announce -$0.77 EPSZacks: Brokerages Anticipate Seattle Genetics, Inc. (NASDAQ:SGEN) to Announce -$0.77 EPS
www.americanbankingnews.com - February 13 at 10:55 AM
FDA accepts Seattle Genetics tucatinib application, action date August 20FDA accepts Seattle Genetics' tucatinib application, action date August 20
seekingalpha.com - February 13 at 9:34 AM
Seattle Genetics Announces FDA Filing Acceptance for Priority Review of Tucatinib New Drug Application (NDA) for Patients with Locally Advanced or Metastatic HER2-Positive Breast CancerSeattle Genetics Announces FDA Filing Acceptance for Priority Review of Tucatinib New Drug Application (NDA) for Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
finance.yahoo.com - February 13 at 9:34 AM
Insider Selling: Seattle Genetics, Inc. (NASDAQ:SGEN) CEO Sells 28,472 Shares of StockInsider Selling: Seattle Genetics, Inc. (NASDAQ:SGEN) CEO Sells 28,472 Shares of Stock
www.americanbankingnews.com - February 13 at 4:08 AM
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri DataThe Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
finance.yahoo.com - February 12 at 12:49 PM
Seattle Genetics (NASDAQ:SGEN) Earns Buy Rating from HC WainwrightSeattle Genetics (NASDAQ:SGEN) Earns Buy Rating from HC Wainwright
www.americanbankingnews.com - February 12 at 7:43 AM
Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer BullseyeSeattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye
www.fool.com - February 11 at 2:31 PM
Seattle Genetics (NASDAQ:SGEN) Receives Buy Rating from JPMorgan Chase & Co.Seattle Genetics (NASDAQ:SGEN) Receives Buy Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - February 11 at 9:58 AM
Seattle Genetics (NASDAQ:SGEN) PT Raised to $165.00Seattle Genetics (NASDAQ:SGEN) PT Raised to $165.00
www.americanbankingnews.com - February 11 at 9:15 AM
Seattle Genetics ADC combo shows positive effect in advanced bladder cancerSeattle Genetics ADC combo shows positive effect in advanced bladder cancer
seekingalpha.com - February 11 at 7:57 AM
Seattle Genetics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest ReportSeattle Genetics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report
finance.yahoo.com - February 10 at 2:31 PM
Equities Analysts Offer Predictions for Seattle Genetics, Inc.s Q2 2020 Earnings (NASDAQ:SGEN)Equities Analysts Offer Predictions for Seattle Genetics, Inc.'s Q2 2020 Earnings (NASDAQ:SGEN)
www.americanbankingnews.com - February 10 at 2:31 AM
Seattle Genetics (NASDAQ:SGEN) Releases Quarterly  Earnings Results, Beats Expectations By $0.60 EPSSeattle Genetics (NASDAQ:SGEN) Releases Quarterly Earnings Results, Beats Expectations By $0.60 EPS
www.americanbankingnews.com - February 7 at 6:47 PM
Piper Sandler Cuts Seattle Genetics (NASDAQ:SGEN) Price Target to Piper Sandler Cuts Seattle Genetics (NASDAQ:SGEN) Price Target to
www.americanbankingnews.com - February 7 at 5:18 PM
Seattle Genetics (NASDAQ:SGEN) Earns Outperform Rating from William BlairSeattle Genetics (NASDAQ:SGEN) Earns Outperform Rating from William Blair
www.americanbankingnews.com - February 7 at 8:31 AM
Seattle Genetics (SGEN) "Buy" Rating Reaffirmed at Needham & Company LLCSeattle Genetics' (SGEN) "Buy" Rating Reaffirmed at Needham & Company LLC
www.americanbankingnews.com - February 7 at 8:08 AM
Seattle Genetics Smashes Wall Street Estimates in Q4, but Its 2020 Guidance DisappointsSeattle Genetics Smashes Wall Street Estimates in Q4, but Its 2020 Guidance Disappoints
www.fool.com - February 7 at 7:28 AM
Edited Transcript of SGEN earnings conference call or presentation 6-Feb-20 9:30pm GMTEdited Transcript of SGEN earnings conference call or presentation 6-Feb-20 9:30pm GMT
finance.yahoo.com - February 7 at 7:28 AM
Seattle Genetics Reports Fourth Quarter and Full Year 2019 Financial ResultsSeattle Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
www.businesswire.com - February 6 at 7:49 PM
Seattle Genetics Reports Q4 Earnings ResultsSeattle Genetics Reports Q4 Earnings Results
www.fool.com - February 6 at 7:49 PM
Seattle Genetics EPS of -$0.14Seattle Genetics EPS of -$0.14
seekingalpha.com - February 6 at 7:49 PM
Seattle Genetics Q4 Adcetris sales up 26%Seattle Genetics Q4 Adcetris sales up 26%
seekingalpha.com - February 6 at 7:49 PM
Seattle Genetics, Inc. to Host Earnings CallSeattle Genetics, Inc. to Host Earnings Call
finance.yahoo.com - February 6 at 2:49 PM
Analysts Offer Predictions for Seattle Genetics, Inc.s FY2024 Earnings (NASDAQ:SGEN)Analysts Offer Predictions for Seattle Genetics, Inc.'s FY2024 Earnings (NASDAQ:SGEN)
www.americanbankingnews.com - February 6 at 2:28 PM
Seattle Genetics Q4 Earnings PreviewSeattle Genetics Q4 Earnings Preview
seekingalpha.com - February 5 at 5:51 PM
Why Seattle Genetics (SGEN) Might Surprise This Earnings SeasonWhy Seattle Genetics (SGEN) Might Surprise This Earnings Season
finance.yahoo.com - February 5 at 12:50 PM
EMA accepts Seattle Genetics tucatinib application for HER2+ breast cancerEMA accepts Seattle Genetics' tucatinib application for HER2+ breast cancer
seekingalpha.com - January 31 at 1:34 PM
EMA Validates Seattle Genetics’ Marketing Authorization Application for Tucatinib for Patients with Locally Advanced or Metastatic HER2-Positive Breast CancerEMA Validates Seattle Genetics’ Marketing Authorization Application for Tucatinib for Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
finance.yahoo.com - January 31 at 8:34 AM
Seattle Genetics (SGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Seattle Genetics (SGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - January 30 at 1:38 PM
Seattle Genetics (SGEN) Scheduled to Post Quarterly Earnings on ThursdaySeattle Genetics (SGEN) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - January 30 at 2:50 AM
Seattle Genetics (NASDAQ:SGEN) Research Coverage Started at BMO Capital MarketsSeattle Genetics (NASDAQ:SGEN) Research Coverage Started at BMO Capital Markets
www.americanbankingnews.com - January 27 at 5:59 PM
Seattle Genetics (NASDAQ:SGEN) Given "Buy" Rating at Royal Bank of CanadaSeattle Genetics (NASDAQ:SGEN) Given "Buy" Rating at Royal Bank of Canada
www.americanbankingnews.com - January 27 at 7:55 AM
Seattle Genetics, Inc. (NASDAQ:SGEN) Receives Consensus Rating of "Buy" from BrokeragesSeattle Genetics, Inc. (NASDAQ:SGEN) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 25 at 5:02 AM
Research Analysts Set Expectations for Seattle Genetics, Inc.s FY2019 Earnings (NASDAQ:SGEN)Research Analysts Set Expectations for Seattle Genetics, Inc.'s FY2019 Earnings (NASDAQ:SGEN)
www.americanbankingnews.com - January 24 at 6:38 AM
FY2021 EPS Estimates for Seattle Genetics, Inc. Reduced by Analyst (NASDAQ:SGEN)FY2021 EPS Estimates for Seattle Genetics, Inc. Reduced by Analyst (NASDAQ:SGEN)
www.americanbankingnews.com - January 23 at 9:01 AM
$223.85 Million in Sales Expected for Seattle Genetics, Inc. (NASDAQ:SGEN) This Quarter$223.85 Million in Sales Expected for Seattle Genetics, Inc. (NASDAQ:SGEN) This Quarter
www.americanbankingnews.com - January 23 at 1:34 AM
Seattle Genetics Achieves Milestone On EU Approval Of Roches PolivySeattle Genetics Achieves Milestone On EU Approval Of Roche's Polivy
www.nasdaq.com - January 21 at 5:12 PM
Seattle Genetics Achieves Milestone Following European Commission Approval of Roche’s Polivy® (Polatuzumab Vedotin)Seattle Genetics Achieves Milestone Following European Commission Approval of Roche’s Polivy® (Polatuzumab Vedotin)
finance.yahoo.com - January 21 at 5:12 PM
Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2019 Financial Results on February 6, 2020Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2019 Financial Results on February 6, 2020
finance.yahoo.com - January 21 at 5:12 PM
Seattle Genetics Up More Than 40% in the Past Year: Heres WhySeattle Genetics Up More Than 40% in the Past Year: Here's Why
finance.yahoo.com - January 20 at 2:54 PM
How Much is Seattle Genetics, Inc.'s (NASDAQ:SGEN) CEO Getting Paid?How Much is Seattle Genetics, Inc.'s (NASDAQ:SGEN) CEO Getting Paid?
finance.yahoo.com - January 16 at 1:10 PM
Nasdaq 100 Movers: SGEN, TSLANasdaq 100 Movers: SGEN, TSLA
www.marketwatch.com - January 13 at 5:29 PM
Why Seattle Genetics Stock Skyrocketed 102% in 2019Why Seattle Genetics Stock Skyrocketed 102% in 2019
www.fool.com - January 12 at 5:13 PM
How Did Seattle Genetics, Inc. (SGEN) Compare Against Top Hedge Fund Stocks in 2019?How Did Seattle Genetics, Inc. (SGEN) Compare Against Top Hedge Fund Stocks in 2019?
finance.yahoo.com - January 9 at 9:17 PM
Nasdaq 100 Movers: SGEN, GOOGLNasdaq 100 Movers: SGEN, GOOGL
www.nasdaq.com - January 6 at 4:17 PM
Seattle Genetics to Present at the J.P. Morgan Healthcare ConferenceSeattle Genetics to Present at the J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 4:17 PM
Nasdaq 100 Movers: SGEN, TCOMNasdaq 100 Movers: SGEN, TCOM
www.marketwatch.com - January 2 at 3:21 PM
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel